Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-11

Clinical Trial Update: Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for atorvastatin and L-Carnitine in non-alcoholic steatohepatitis; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN